ADPTNasdaq United States
Market cap
$3.979 B
$24.93 +5.64%
Close of 7 Aug 2026
Revenue
$277.0M
#2172 by revenue
Earnings
-$59.5M
Loss-making
Shares outstanding
159,595,842
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Adaptive Biotechnologies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.